Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes
Aim. To assess the relationship between type 2 diabetes (T2D) and the course and outcomes of coronavirus disease 2019 (COVID-19), depending on clinical and laboratory parameters and comorbidities.Material and methods. A retrospective analysis of clinical outcomes was carried out in 1985 patients wit...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2021-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2750 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850030418183585792 |
|---|---|
| author | T. Yu. Demidova K. G. Lobanova S. N. Perekhodov M. B. Antsiferov O. Sh. Oynotkinova |
| author_facet | T. Yu. Demidova K. G. Lobanova S. N. Perekhodov M. B. Antsiferov O. Sh. Oynotkinova |
| author_sort | T. Yu. Demidova |
| collection | DOAJ |
| description | Aim. To assess the relationship between type 2 diabetes (T2D) and the course and outcomes of coronavirus disease 2019 (COVID-19), depending on clinical and laboratory parameters and comorbidities.Material and methods. A retrospective analysis of clinical outcomes was carried out in 1985 patients with documented COVID-19 who were admitted to the V. P. Demikhov City Clinical Hospital in the period from March 23, 2020 to June 01, 2020. Subsequently, 232 patients were excluded due to their transfer to another hospital. The final analysis included 1753 patients, of which 311 (17,7%) patients had T2D.Results. T2D was associated with an unfavorable outcome of COVID-19: mortality with and without — 16,1% and 7,4% (p<0,001). Age >60 years increased the mortality of patients with COVID-19, especially with concomitant T2D: patients <60 years of age without T2D — 2,2%, with T2D — 5,4% (p<0,05); patients >60 years of age without T2D — 15,6%, with T2D — 22,1% (p<0,01). Sex was not associated with mortality among COVID-19 patients. Among patients without T2D, the glycemia-depended mortality curves were U-shaped: 3,7% with glycemia <6,1 mmol/L, 1,1% with glycemia in the range of 6,17,0 mmol/L, 10,8% with glycemia >7,0 mmol/L (p<0,001). In patients with COVID-19 and T2D, a direct relationship was found between the level of glycemia and mortality: with glycemia <6,1 mmol/L, mortality rate was 8,3%, while with glycemia in the range of 6,1-7,0 mmol/L — 11,8% and glycemia >7 mmol/L — 15,6% (p<0,001). Any comorbidity worsened the outcome in COVID-19 patients. The highest mortality rate was observed in the presence of chronic obstructive pulmonary disease (46,2%; p<0,001), coronary artery disease (26,3%; p<0,001), cancer 25% (p<0,001). T2D significantly increased mortality among patients with chronic obstructive pulmonary disease — 33,3 vs 75% (p<0,05), asthma — 7,1 vs 60% (p<0,001), and cancer — 12,5 vs 62,5% (p<0,01).Conclusion. T2D is associated with unfavorable COVID-19 outcomes, especially among patients >60 years of age and high blood glucose levels. Any concomitant disease worsened the outcome of the disease. The main cause of death from COVID-19 were complications: acute respiratory distress syndrome, sepsis, acute renal failure, thrombotic events. |
| format | Article |
| id | doaj-art-2fcc6a10ed04401fbcb21bc3b2740d57 |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2021-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-2fcc6a10ed04401fbcb21bc3b2740d572025-08-20T02:59:14Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252021-02-0120110.15829/1728-8800-2021-27502223Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetesT. Yu. Demidova0K. G. Lobanova1S. N. Perekhodov2M. B. Antsiferov3O. Sh. Oynotkinova4Pirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityDemikhov City Clinical HospitalEndocrinology Dispensary of the Moscow Healthcare DepartmentPirogov Russian National Research Medical UniversityAim. To assess the relationship between type 2 diabetes (T2D) and the course and outcomes of coronavirus disease 2019 (COVID-19), depending on clinical and laboratory parameters and comorbidities.Material and methods. A retrospective analysis of clinical outcomes was carried out in 1985 patients with documented COVID-19 who were admitted to the V. P. Demikhov City Clinical Hospital in the period from March 23, 2020 to June 01, 2020. Subsequently, 232 patients were excluded due to their transfer to another hospital. The final analysis included 1753 patients, of which 311 (17,7%) patients had T2D.Results. T2D was associated with an unfavorable outcome of COVID-19: mortality with and without — 16,1% and 7,4% (p<0,001). Age >60 years increased the mortality of patients with COVID-19, especially with concomitant T2D: patients <60 years of age without T2D — 2,2%, with T2D — 5,4% (p<0,05); patients >60 years of age without T2D — 15,6%, with T2D — 22,1% (p<0,01). Sex was not associated with mortality among COVID-19 patients. Among patients without T2D, the glycemia-depended mortality curves were U-shaped: 3,7% with glycemia <6,1 mmol/L, 1,1% with glycemia in the range of 6,17,0 mmol/L, 10,8% with glycemia >7,0 mmol/L (p<0,001). In patients with COVID-19 and T2D, a direct relationship was found between the level of glycemia and mortality: with glycemia <6,1 mmol/L, mortality rate was 8,3%, while with glycemia in the range of 6,1-7,0 mmol/L — 11,8% and glycemia >7 mmol/L — 15,6% (p<0,001). Any comorbidity worsened the outcome in COVID-19 patients. The highest mortality rate was observed in the presence of chronic obstructive pulmonary disease (46,2%; p<0,001), coronary artery disease (26,3%; p<0,001), cancer 25% (p<0,001). T2D significantly increased mortality among patients with chronic obstructive pulmonary disease — 33,3 vs 75% (p<0,05), asthma — 7,1 vs 60% (p<0,001), and cancer — 12,5 vs 62,5% (p<0,01).Conclusion. T2D is associated with unfavorable COVID-19 outcomes, especially among patients >60 years of age and high blood glucose levels. Any concomitant disease worsened the outcome of the disease. The main cause of death from COVID-19 were complications: acute respiratory distress syndrome, sepsis, acute renal failure, thrombotic events.https://cardiovascular.elpub.ru/jour/article/view/2750type 2 diabetessars-cov-2covid-19mortality |
| spellingShingle | T. Yu. Demidova K. G. Lobanova S. N. Perekhodov M. B. Antsiferov O. Sh. Oynotkinova Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes Кардиоваскулярная терапия и профилактика type 2 diabetes sars-cov-2 covid-19 mortality |
| title | Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes |
| title_full | Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes |
| title_fullStr | Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes |
| title_full_unstemmed | Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes |
| title_short | Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes |
| title_sort | clinical and laboratory characteristics of patients with covid 19 and concomitant type 2 diabetes |
| topic | type 2 diabetes sars-cov-2 covid-19 mortality |
| url | https://cardiovascular.elpub.ru/jour/article/view/2750 |
| work_keys_str_mv | AT tyudemidova clinicalandlaboratorycharacteristicsofpatientswithcovid19andconcomitanttype2diabetes AT kglobanova clinicalandlaboratorycharacteristicsofpatientswithcovid19andconcomitanttype2diabetes AT snperekhodov clinicalandlaboratorycharacteristicsofpatientswithcovid19andconcomitanttype2diabetes AT mbantsiferov clinicalandlaboratorycharacteristicsofpatientswithcovid19andconcomitanttype2diabetes AT oshoynotkinova clinicalandlaboratorycharacteristicsofpatientswithcovid19andconcomitanttype2diabetes |